Research and Markets: Decision Matrix: Selecting A CRM Vendor in the Pharmaceutical Industry
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c78099) has announced the addition of “Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Industry (Competitor Focus)” to their offering.
Introduction
This report provides a comparative analysis of the leading CRM vendors in the pharmaceutical market in order to help companies select a CRM solution based on its technology strength, reputation amongst end users and ability to influence the market.
Scope
Identifies which technology vendors pharmaceutical companies should ‘shortlist’ when considering the purchase of a CRM solution. Provides a comparative technology assessment of the CRM solutions offered by leading vendors in the pharmaceutical market, globally Identifies which CRM solution providers have the most impact on the pharmaceutical market Explores how end users perceive CRM vendors across eight categories such as product quality and service capabilities
Highlights
By combining robust CRM technology with extensive market impact in the pharmaceutical sector, Oracle is positioned as the leader for CRM solutions in the life sciences; With its recent acquisition of Dendrite, Cegedim has increased its market impact and has positioned itself as an important leader in the pharmaceutical CRM market; By offering new technology platforms StayinFront and Salesforce.com have become important players in the pharmaceutical CRM landscape; and While still a newcomer, Verticals onDemand, boasts domain expertise and a competitive end-user interface.
Reasons to Purchase
Understand the topography of the competitive landscape for CRM in the pharmaceutical industry Identify the strengths and weaknesses of leading CRM vendors and their solutions Obtain insight into how IT managers in Pharma perceive key vendors in the market for CRM
Companies Mentioned:
- Future plc
- Oracle Corporation
For more information, visit http://www.researchandmarkets.com/reports/c78099.
|
